synthetic stimulants

content keywords
The content title Keyword(s)
High-risk drug use and new psychoactive substances death | new psychoactive substances (NPS) | problem drug use | recreational drugs | synthetic stimulants
Harms arising from the use of synthetic cannabinoid products (poster) synthetic stimulants
Health responses to new psychoactive substances best practice | emerging topics | health effects | injection | new psychoactive substances (NPS) | prevention | prison | problem drug use | recreational drugs | synthetic drugs | synthetic stimulants | treatment | young people
Synthetic cannabinoids in Europe (Perspectives on drugs) health effects | prevalence | synthetic drugs | synthetic stimulants
European Drug Report 2015: Trends and Developments alcohol | amphetamines | cannabis | chemistry | co-morbidity | cocaine | consumption rooms | crime | death | demand | drug-law offences | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | methodology | new psychoactive substances (NPS) | older people | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | Reitox | research | seizures | social exclusion | social reintegration | spice | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people
2009 Annual report on the state of the drugs problem in Europe amphetamines | cannabis | co-morbidity | cocaine | demand | drug-law offences | emcdda | epidemiology | evaluation | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends
European Drug Report 2014: Trends and developments amphetamines | cannabis | cocaine | crime | death | demand | drug-law offences | harm reduction | health effects | heroin | infectious diseases | injecting | key indicators | markets | new psychoactive substances (NPS) | opioids | overdose | policy | prevalence | prevention | price | prison | problem drug use | recreational drugs | seizures | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people
2010 Annual report on the state of the drugs problem in Europe amphetamines | cannabis | co-morbidity | cocaine | crime | death | demand | drug-law offences | emcdda | epidemiology | gender | hallucinogens | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends
Exploring methamphetamine trends in Europe amphetamines | harm reduction | health effects | history | synthetic stimulants
EMCDDA–Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine) new psychoactive substances (NPS) | synthetic stimulants
Loading